Primary Site >> Stomach Cancer
Gene >> EGFR
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. PMID: 2430175 Ref: DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer. PMID: 3102422 |
Ref: [Correlation of epidermal growth factor receptor status and clinical outcome in gastric carcinoma]. PMID: 2849039 Ref: [Immunohistochemical study of epidermal growth factor receptor in gastric carcinoma]. PMID: 3185483 |
Ref: Regulation of expression and transforming ability of the c-erbB-2 gene. PMID: 2577338 Ref: Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma. PMID: 2647276 Ref: Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. PMID: 2702651 |
Ref: DNA ploidy pattern and amplification of ERBB and ERBB2 genes in human gastric carcinomas. PMID: 1970690 Ref: Growth factors in progression of human esophageal and gastric carcinomas. PMID: 2098274 Ref: Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. PMID: 2108945 Ref: Growth factors and oncogenes in human gastrointestinal carcinomas. PMID: 2157713 Ref: Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-alpha in human gastric carcinoma cell line MKN-28. PMID: 2168868 |
Ref: Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. PMID: 1670998 Ref: Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. PMID: 1673870 Ref: Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. PMID: 1677259 Ref: Tissue status of epidermal growth factor and its receptor as an indicator of poor prognosis in patients with gastric cancer. PMID: 1751401 Ref: Effects of tyrosine kinase inhibitor, erbstatin, on cell growth and growth-factor/receptor gene expression in human gastric carcinoma cells. PMID: 1849125 Ref: Increased production of growth factors and epidermal growth factor receptor by gastric carcinoma. PMID: 2044780 Ref: [Oncogene and patient prognosis]. PMID: 2053766 |
Ref: The level of a transcription factor Sp1 is correlated with the expression of EGF receptor in human gastric carcinomas. PMID: 1282800 Ref: [Gastric cancer: epidermal growth factor and epidermal growth factor receptor]. PMID: 1305311 Ref: Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridiz PMID: 1317752 Ref: Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma. PMID: 1348293 Ref: [Expression of c-erbB-2 protein in gastric carcinomas--correlation between immunohistochemical study and clinico-pathological factors, DNA ploidy pattern and concentration of c-erbB-2 protein in serum]. PMID: 1350646 Ref: Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. PMID: 1355336 Ref: Clinical significance of erbB-2 (HER-2/neu) protein. PMID: 1358410 Ref: [Effects of EGF, anti-EGF and anti-EGFR antibodies on the growth of human cancer cells]. PMID: 1473218 Ref: Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer. PMID: 1574253 Ref: Tyrosine kinase activity of epidermal growth factor receptor in human gastric carcinomas. PMID: 1594497 |
Ref: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. PMID: 7688814 Ref: Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival. PMID: 7901825 Ref: Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. PMID: 7902202 Ref: [Expression of the growth factors (EGF, EGFR, and TGF alpha) and PCNA in superspreading and penetrating types of gastric carcinomas]. PMID: 7902525 Ref: Immunohistochemical detection of p53 protein, c-erbB-2 protein, epidermal growth factor receptor protein and proliferating cell nuclear antigen in gastric carcinoma. PMID: 7911025 Ref: An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator? PMID: 8093216 Ref: [Immunohistochemical study of the c-erbB-2 protein in human gastric carcinoma]. PMID: 8094883 Ref: Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients. PMID: 8096502 Ref: [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas]. PMID: 8098198 Ref: The mechanism of c-erbB-2 gene product increase in stomach cancer cell lines. PMID: 8104420 Ref: [Expression of EGF-R in gastric carcinoma and precancerous lesion]. PMID: 8261863 Ref: Epidermal growth factor-like growth factors. I. Breast malignancies and other epithelial proliferations in transgenic mice. PMID: 8264229 Ref: [Immunohistochemical and histopathological study of expression of epidermal growth factor receptors in gastric cancer]. PMID: 8272061 Ref: Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. PMID: 8297123 Ref: Epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. PMID: 8312682 Ref: Interleukin 1 alpha acts as an autocrine growth stimulator for human gastric carcinoma cells. PMID: 8358739 Ref: Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. PMID: 8387462 Ref: Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer. PMID: 8397058 Ref: GC factor represses transcription of several growth factor/receptor genes and causes growth inhibition of human gastric carcinoma cell lines. PMID: 8494791 Ref: Serum erbb-2 protein for the diagnosis of gastric-cancer. PMID: 21573368 Ref: Expression of transforming growth factor-alpha, epidermal growth-factor receptor and proliferating cell nuclear antigen in gastric-carcinoma - an immunohistochemical study. PMID: 21573535 Ref: Evidence of autocrine mechanism in poorly differentiated adenocarcinoma of the stomach. PMID: 21573605 Ref: Prediction of the prognosis of patients with gastric-cancer by erbb-2 tissue status and expression of proliferating cell nuclear antigen. PMID: 21573666 |
Ref: Serum levels of c-erbB-2 protein in digestive diseases. PMID: 7528080 Ref: Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma. PMID: 7907854 Ref: Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. PMID: 7952499 Ref: Stimulatory effect of EGF and inhibitory effect of sialoadenectomy on growth of an EGF receptor-hyperproducing human gastric cancer xenograft in nude mice. PMID: 7981544 Ref: [Clinical study on epidermal growth factor and its receptor in human gastric cancer]. PMID: 7987713 Ref: Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer. PMID: 7991990 Ref: The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors. PMID: 7993593 Ref: Augmentation of 5-fluorouracil cytotoxicity by epidermal growth factor in a newly established human signet-ring cell carcinoma of the stomach in culture. PMID: 8054813 Ref: [Expression of human epidermal growth factor and its receptor of the gastric carcinomas with special reference to DNA ploidy patterns and nucleolar organizer regions]. PMID: 8177199 Ref: Bilateral Breast Cancer in a Patient with a Strong Family History of Cancer: Analysis of p53 Germ Line Mutations. PMID: 11091524 Ref: Immunohistochemical detection of cripto-1, amphiregulin and transforming growth-factor-alpha in human gastric carcinomas and intestinal metaplasias. PMID: 21559578 |
Ref: Are Japanese and European gastric cancer the same biological entity? An immunohistochemical study. PMID: 7547252 Ref: Establishment of two new scirrhous gastric cancer cell lines: analysis of factors associated with disseminated metastasis. PMID: 7577468 Ref: Growth of human gastric carcinomas and expression of epidermal growth factor, transforming growth factor-alpha, epidermal growth factor receptor and p185c-erbB-2. PMID: 7637956 Ref: Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer. PMID: 7715901 Ref: Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer. PMID: 7715902 Ref: Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. PMID: 7819044 Ref: Establishment and characterization of TSGH9201, a human gastric carcinoma cell line that is growth inhibited by epidermal growth factor. PMID: 7823569 Ref: Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer. PMID: 7889468 Ref: [The role of endoscopic ultrasonography and epidermal growth factor receptor assay in preoperative staging for gastric carcinoma]. PMID: 8731844 |
Ref: Inhibitory effect of anti-epidermal growth factor receptor antibody on a human gastric cancer. PMID: 8608556 Ref: Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. PMID: 8621250 Ref: Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain. PMID: 8643220 Ref: The relationship between mast cell infiltration and the expression of PCNA and EGFr in experimental hepatocellular carcinoma of liver and squamous cell carcinoma of stomach in rats. PMID: 8758735 Ref: Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. PMID: 8806677 Ref: Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. PMID: 8925130 Ref: Hereditary onset of multiple seborrheic keratoses: a variant of Leser Trelat sign? PMID: 8935630 Ref: [Correlation of multiple gene changes with malignant phenotype of human gastric carcinoma]. PMID: 9275549 Ref: [Multiple genetic expression abnormalities in gastric cancer]. PMID: 9387254 Ref: Growth inhibition of gastric cancer cell lines by the tyrphostin RG13022 and its effects on intracellular signalling. PMID: 21544401 |
Ref: Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients. PMID: 9149012 Ref: Growth inhibition of cultured human gastric cancer cells by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein. PMID: 9342842 Ref: Comparative evaluation of cell proliferative indices and epidermal growth factor receptor expression in gastric carcinoma. PMID: 9444859 Ref: [The correlation of TGF-alpha, EGFR in precancerous lesions and carcinoma of stomach with PCNA expression]. PMID: 10072847 |
Ref: Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization. PMID: 9520947 Ref: Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach. PMID: 9544434 Ref: Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. PMID: 9703936 Ref: Oxidative stress activates the human histidine decarboxylase promoter in AGS gastric cancer cells. PMID: 9722530 Ref: Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features. PMID: 9732228 Ref: Expression of cadherin-catenin cell adhesion molecules, phosphorylated tyrosine residues and growth factor receptor-tyrosine kinases in gastric cancers. PMID: 9765619 Ref: Immunohistochemical demonstration of angiogenic growth factors and EGF receptor in hepatic metastases and primary human gastric cancer. PMID: 9808988 |
Ref: Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas. PMID: 9973227 Ref: Expression of epidermal growth factor receptor and CD44 splicing variants sharing exons 6 and 9 on gastric and esophageal carcinomas: a two-color flow-cytometric analysis. PMID: 10037277 Ref: Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67. PMID: 10393360 Ref: The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer. PMID: 10446693 Ref: Effect of thiazinotrienomycin B, an ansamycin antibiotic, on the function of epidermal growth factor receptor in human stomach tumor cells. PMID: 10480573 Ref: Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer. PMID: 10505852 Ref: Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor. PMID: 10520838 Ref: Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells. PMID: 10535875 Ref: Detection of transforming growth factor-alpha in the serum of gastric carcinoma patients. PMID: 10545793 Ref: A novel epidermal growth factor-like molecule containing two follistatin modules stimulates tyrosine phosphorylation of erbB-4 in MKN28 gastric cancer cells. PMID: 10600548 Ref: Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types. PMID: 10619912 |
Ref: Comparative study of tumor angiogenesis and immunohistochemistry for p53, c-ErbB2, c-myc and EGFr as prognostic factors in gastric cancer. PMID: 10809364 Ref: Epidermal growth factor and 17beta-estradiol effects on proliferation of a human gastric cancer cell line (AGS). PMID: 10972181 Ref: c-erbB-2 protein expression and clinicopathologic features in colorectal cancer. PMID: 11032920 |
Ref: Critical role of extracellular signal-regulated kinase phosphorylation on menadione (vitamin K3) induced growth inhibition. PMID: 11267961 Ref: Clinical significance of epidermal growth factor receptor content in gastric cancer. PMID: 11605731 Ref: Evaluation of the epidermal growth factor receptor (EGFR) and c-erbB-2 in superspreading-type and penetrating-type gastric carcinoma. PMID: 11680933 |
Ref: Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay. PMID: 11948459 Ref: EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. PMID: 12115496 Ref: [Relationship between recurrence and metastasis of gastric cancer and expression of EGFR, IL-6R, PCNA, and DI]. PMID: 12479108 Ref: The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma. PMID: 12579211 Ref: Antitumor Activity of Oxaliplatin, 5-FU and Paclitaxel Given Alone or in Combination with ZD1839 in Human Gastric Carcinoma Cells in vitro. PMID: 26680890 |
Ref: Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. PMID: 12679307 Ref: Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options. PMID: 12790326 Ref: Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer. PMID: 14535591 Ref: The Prognostic Significance of the Overexpression of HER-2/ neu in Korean Gastric Carcinomas and the In Vitro Effects of Anti-HER-2/neu Antibody on Cell Growth in the Gastric Carcinoma Cell Lines. PMID: 26680923 |
Ref: Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. PMID: 14699500 Ref: Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism. PMID: 14764442 Ref: Expression of Cbl linking with the epidermal growth factor receptor system is associated with tumor progression and poor prognosis of human gastric carcinoma. PMID: 14991403 Ref: Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer. PMID: 15007244 Ref: Increased tyrosine kinase activites may lead to the phenotypic differences of gastric cancer cells. PMID: 15161014 Ref: Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. PMID: 15245777 Ref: Monoclonal antibodies as effective therapeutic agents for solid tumors. PMID: 15298722 Ref: The mechanism of cleavage of EGFR ligands induced by inflammatory cytokines in gastric cancer cells. PMID: 15300588 Ref: [Proliferative changes of human gastric mucosa cells in different pathological lesions and their clinical significance]. PMID: 15355661 Ref: ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer. PMID: 15367698 Ref: A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. PMID: 15517369 Ref: Sphingosine 1-phosphate transactivates c-Met as well as epidermal growth factor receptor (EGFR) in human gastric cancer cells. PMID: 15556605 Ref: Prognostic significance of immunohistochemical expression of EGFR and C-erbB-2 oncoprotein in curatively resected gastric cancer. PMID: 20368841 |
Ref: Reduced expression of epidermal growth factor receptor related protein in gastric cancer. PMID: 15647181 Ref: Lysophospholipids transactivate HER2/neu (erbB-2) in human gastric cancer cells. PMID: 15649431 Ref: Gefitinib (Iressa, ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells. PMID: 15723219 Ref: Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N'-{4-(4-quinolyloxy)phenyl}ureas. PMID: 15743179 Ref: MCI-186 inhibits tumor growth through suppression of EGFR phosphorylation and cell cycle arrest. PMID: 15868956 Ref: Usefulness and limitation of multiple endoscopic biopsy sampling for epidermal growth factor receptor and c-erbB-2 testing in patients with gastric adenocarcinoma. PMID: 15928192 Ref: Novel targeted therapies in the treatment of gastric and esophageal cancer. PMID: 15980157 Ref: PGE2 up-regulates vascular endothelial growth factor expression in MKN28 gastric cancer cells via epidermal growth factor receptor signaling system. PMID: 15995627 Ref: Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis. PMID: 16086234 Ref: Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. PMID: 16230373 Ref: ERBB2 kinase domain mutation in a gastric cancer metastasis. PMID: 16309427 |
Ref: ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. PMID: 16052530 Ref: Somatic mutations of the ERBB4 kinase domain in human cancers. PMID: 16187281 Ref: The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers. PMID: 16353180 Ref: Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas. PMID: 16397024 Ref: Heparin increases human gastric carcinoma cell growth. PMID: 16475731 Ref: Mutations of the epidermal growth factor receptor gene in gastrointestinal tract tumor cell lines. PMID: 16596188 Ref: Molecular characteristics of differentiated-type gastric carcinoma with distinct mucin phenotype: LI-cadherin is associated with intestinal phenotype. PMID: 16634965 Ref: Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation. PMID: 16816379 Ref: Novel targets in gastric and esophageal cancer. PMID: 16829119 Ref: The relation of pepsinogen group II (PGII) expression to intestinal metaplasia and gastric cancer. PMID: 16842245 Ref: Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancer. PMID: 16865277 Ref: Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha. PMID: 16918998 Ref: Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma. PMID: 16963731 Ref: Mutational analysis of AKT1, AKT2 and AKT3 genes in common human carcinomas. PMID: 17047397 Ref: Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127. PMID: 17050876 Ref: Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis. PMID: 17088902 Ref: Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer. PMID: 17094480 |
Ref: Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. PMID: 17214962 Ref: Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways. PMID: 17332476 Ref: Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. PMID: 17363505 Ref: EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells. PMID: 17510211 Ref: Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. PMID: 17516110 Ref: Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer. PMID: 17617207 Ref: [Effect of Xiaotan Sanjie Recipe on growth of transplanted tumor and expressions of proliferating cell nuclear antigen and epidermal growth factor receptor in tissue of gastric carcinoma of nude mice]. PMID: 17631808 Ref: Relation of neuroendocrine cells to transforming growth factor-alpha and epidermal growth factor receptor expression in gastric adenocarcinomas: prognostic implications. PMID: 17922051 Ref: [Effect of gefitinib on radiosensitivity of gastric cancer cell lines]. PMID: 18076795 |
Ref: Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. PMID: 17628829 Ref: Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. PMID: 17896140 Ref: Epidermal growth factor receptor structural alterations in gastric cancer. PMID: 18199332 Ref: EGFR as a Prognostic Marker for Gastric Cancer. PMID: 18224475 Ref: Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. PMID: 18231104 Ref: Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. PMID: 18245470 Ref: Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. PMID: 18258606 Ref: Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer. PMID: 18259945 Ref: FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. PMID: 18381441 Ref: EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. PMID: 18397279 Ref: Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity. PMID: 18422755 Ref: Impact of insulin-like growth factor type 1 receptor, epidermal growth factor receptor, and HER2 expressions on outcomes of patients with gastric cancer. PMID: 18483367 Ref: New drugs in the treatment of gastric tumors. PMID: 18490241 Ref: Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma. PMID: 18505086 Ref: Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer. PMID: 18544998 Ref: Suppression of proHB-EGF carboxy-terminal fragment nuclear translocation: a new molecular target therapy for gastric cancer. PMID: 18559618 Ref: Targeted inhibition of Sp1-mediated transcription for antiangiogenic therapy of metastatic human gastric cancer in orthotopic nude mouse models. PMID: 18575762 Ref: Does hyaluronic acid stimulate tumor growth after endoscopic mucosal resection? PMID: 18637056 Ref: Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion. PMID: 18701480 Ref: The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. PMID: 18774637 Ref: Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. PMID: 18798223 Ref: HER kinase activation confers resistance to MET tyrosine kinase inhibition in MET oncogene-addicted gastric cancer cells. PMID: 18974395 Ref: Molecular targets and biological modifiers in gastric cancer. PMID: 19013893 Ref: Epidermal growth factor receptor as a predictor of tumor response to preoperative chemoradiation in locally advanced gastric carcinoma. PMID: 19016018 Ref: High expression of HER3 is associated with a decreased survival in gastric cancer. PMID: 19047113 Ref: Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients. PMID: 19061514 Ref: [Correlation of Helicobacter pylori infection with the expression of COX-2 and EGFR and VEGF in human gastric carcinoma]. PMID: 19173907 |
Ref: Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation. PMID: 19082474 Ref: Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer. PMID: 19127259 Ref: Reg IV enhances peritoneal metastasis in gastric carcinomas. PMID: 19143768 Ref: Obestatin stimulates Akt signalling in gastric cancer cells through beta-arrestin-mediated epidermal growth factor receptor transactivation. PMID: 19153210 Ref: Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology. PMID: 19236713 Ref: Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival. PMID: 19259093 Ref: Targeting apoptosis as an approach for gastrointestinal cancer therapy. PMID: 19278896 Ref: Significant association between EGFR-mutated lung adenocarcinoma and past illness from gastric cancer or uterine myoma: its implication in carcinogenesis. PMID: 19362747 Ref: Gastric cancer in the era of molecularly targeted agents: current drug development strategies. PMID: 19363621 Ref: Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. PMID: 19448398 Ref: Novel investigational drugs for gastric cancer. PMID: 19466878 Ref: Mucinous gastric carcinomas: clinicopathologic and molecular analyses. PMID: 19479974 Ref: [Advances in genome analysis of solid tumors]. PMID: 19507502 Ref: The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. PMID: 19536776 Ref: [EGFR-blockade by antibody Cetuximab inhibits the growth of human gastric cancer xenograft in nude mice and its possible mechanism]. PMID: 19538880 Ref: Down-regulation of epidermal growth factor receptor by selective expansion of a 5'-end regulatory dinucleotide repeat in colon cancer with microsatellite instability. PMID: 19584170 Ref: ERBB2 suppression decreases cell growth via apoptosis in gastrointestinal adenocarcinomas. PMID: 19628076 Ref: Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept. PMID: 19636422 Ref: Comparative study on overexpression of HER2/neu and HER3 in gastric cancer. PMID: 19636613 Ref: Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer. PMID: 19639197 Ref: [Differential expression of immunohistochemical markers between cardiac carcinoma and carcinoma in antrum of stomach and correlation thereof with clinicopathological factors]. PMID: 19671307 Ref: Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells. PMID: 19755509 Ref: Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue. PMID: 19783961 Ref: Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT). PMID: 19849847 Ref: Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma. PMID: 20164030 Ref: Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach. PMID: 20430735 |
Ref: Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibility to intestinal-type gastric cancer. PMID: 19655167 Ref: Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. PMID: 19757047 Ref: Use of protein array to investigate receptor tyrosine kinases activated in gastric cancer. PMID: 19956838 Ref: Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways. PMID: 20039326 Ref: Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6. PMID: 20047592 Ref: Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). PMID: 20068568 Ref: Esophagogastric cancer: targeted agents. PMID: 20122806 Ref: Population-based differences in treatment outcome following anticancer drug therapies. PMID: 20129130 Ref: A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer. PMID: 20130877 Ref: [4, 8-disubstituted-8, 9-dihydro-pyrazine[2,3-g]quinazoline-7(6H)-ketones: a novel class of antitumor agents]. PMID: 20175236 Ref: Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo. PMID: 20179222 Ref: [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation]. PMID: 20353702 Ref: KRAS mutant lung cancer cells are differentially responsive to MEK inhibitor due to AKT or STAT3 activation: implication for combinatorial approach. PMID: 20358631 Ref: Cetuximab enhances the effect of oxaliplatin on hypoxic gastric cancer cell lines. PMID: 20428833 Ref: Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition. PMID: 20500904 Ref: Overexpression of p73 as a tissue marker for high-risk gastritis. PMID: 20530692 Ref: Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor. PMID: 20587521 Ref: Genetic profiles of gastroesophageal cancer: combined analysis using expression array and tiling array--comparative genomic hybridization. PMID: 20620594 Ref: Micropapillary carcinoma of stomach: a clinicopathologic and immunohistochemical study of 11 cases. PMID: 20661012 Ref: [Impact of HER2, EGFR, IGF-1R, and VEGFR expressions on the outcome of chemotherapy for advanced gastric cancer]. PMID: 20716873 Ref: The activation of Proteinase-Activated Receptor-1 (PAR1) mediates gastric cancer cell proliferation and invasion. PMID: 20723226 Ref: [Effects of EGFR inhibitor AG1478 in combination with celecoxib on the growth of gastric cancer cells]. PMID: 20848776 Ref: TGFbeta induces proHB-EGF shedding and EGFR transactivation through ADAM activation in gastric cancer cells. PMID: 20934403 Ref: Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity. PMID: 20937115 Ref: Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitro. PMID: 20977754 Ref: Inhibitory effects of cytoplasmic-domain substituted epidermal growth factor receptor on growth, invasion and angiogenesis in human gastric cancer cells. PMID: 21472235 |
Ref: Oncogenic mutations in gastric cancer with microsatellite instability. PMID: 20937558 Ref: Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. PMID: 20975737 Ref: Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis. PMID: 21205091 Ref: A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma. PMID: 21217058 Ref: Multiple mutations and bypass mechanisms can contribute to development of acquired resistance to MET inhibitors. PMID: 21266357 Ref: [Recent results of research on cancer of the colon, gastric cancer, sarcoma and bronchial carcinoma]. PMID: 21271476 Ref: A functional and transcriptomic analysis of NET1 bioactivity in gastric cancer. PMID: 21284875 Ref: Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan. PMID: 21286718 Ref: Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report. PMID: 21346384 Ref: [Expression and clinical significance of epidermal growth factor receptor and protein kinase B in gastric carcinoma]. PMID: 21365510 Ref: Molecularly targeted therapies in advanced gastric cancer. PMID: 21372772 Ref: Prognostic analysis of familial gastric cancer in Chinese population. PMID: 21400534 Ref: Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer. PMID: 21415234 Ref: Epidermal growth factor receptor mutation in gastric cancer. PMID: 21436633 Ref: 15-hydroxyprostaglandin dehydrogenase is downregulated and exhibits tumor suppressor activity in gastric cancer. PMID: 21469975 Ref: The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. PMID: 21482691 Ref: Ror1 is a pseudokinase that is crucial for Met-driven tumorigenesis. PMID: 21487037 Ref: Clinical significance of miR-146a in gastric cancer cases. PMID: 21632853 Ref: Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridization. PMID: 21689422 Ref: Pertuzumab in combination with trastuzumab shows significantly enhanced antitumor activity in HER2-positive human gastric cancer xenograft models. PMID: 21700765 Ref: Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome. PMID: 21709195 Ref: The role of neuregulin4 and HER4 in gastrointestinal malignant lymphoma. PMID: 21805036 Ref: Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. PMID: 21811258 Ref: An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells. PMID: 21997136 Ref: Antitumour activity of S-1 in combination with cetuximab on human gastric cancer cell lines in vivo. PMID: 22110188 Ref: Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). PMID: 22152101 Ref: Epidermal growth factor receptor overexpression/amplification in adenocarcinomas arising in the gastrointestinal tract. PMID: 22217347 Ref: [Phase I study of anti-EGFR monoclonal antibody (CMAB009) in patients with advanced cancer]. PMID: 22321747 Ref: Prognostic value of co-expression of STAT3, mTOR and EGFR in gastric cancer. PMID: 22977493 Ref: Identification of novel molecular markers for detection of gastric cancer cells in the peripheral blood circulation using genome-wide microarray analysis. PMID: 22977563 |
Ref: Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy. PMID: 21173787 Ref: Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies. PMID: 21256046 Ref: Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks. PMID: 21655918 Ref: Antitumor activity of HM781-36B, a highly effective pan-HER inhibitor in erlotinib-resistant NSCLC and other EGFR-dependent cancer models. PMID: 21732342 Ref: In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype. PMID: 22011788 Ref: Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. PMID: 22012247 Ref: Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines. PMID: 22036905 Ref: Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer. PMID: 22048943 Ref: LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. PMID: 22085492 Ref: Evaluation of the antitumor effects and mechanisms of PF00299804, a pan-HER inhibitor, alone or in combination with chemotherapy or targeted agents in gastric cancer. PMID: 22135232 Ref: Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells. PMID: 22139134 Ref: Multi-parametric approach to identify coffee components that regulate mechanisms of gastric acid secretion. PMID: 22147653 Ref: MET activation mediates resistance to lapatinib inhibition of HER2-amplified gastric cancer cells. PMID: 22238368 Ref: Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules. PMID: 22286119 Ref: Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines. PMID: 22290393 Ref: A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. PMID: 22315472 Ref: Nuclear translocation of pro-amphiregulin induces chemoresistance in gastric cancer. PMID: 22320154 Ref: [Sorting of CD133(+) subset cells in human gastric cancer and the identification of their tumor initiating cell-like properties]. PMID: 22368028 Ref: Safety, efficacy and pharmacokinetics of neratinib (HKI-272) in Japanese patients with advanced solid tumors: a Phase 1 dose-escalation study. PMID: 22371427 Ref: Current status of targeted therapies in advanced gastric cancer. PMID: 22443228 Ref: [Clinicopathological features of 8 patients with metastatic gastric tumors]. PMID: 22481259 Ref: Gene silencing of EREG mediated by DNA methylation and histone modification in human gastric cancers. PMID: 22508389 Ref: An association between EGF and EGFR gene polymorphisms with gastric cancer in a Chinese Han population. PMID: 22534548 Ref: Tumor size predicts survival in mucinous gastric carcinoma. PMID: 22535583 Ref: Targeted therapy for gastric cancer. PMID: 22552927 Ref: The correlations between the expression of FGFR4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients. PMID: 22585711 Ref: Inhibition of the mTOR/S6K signal is necessary to enhance fluorouracil-induced apoptosis in gastric cancer cells with HER2 amplification. PMID: 22614071 Ref: Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines. PMID: 22614881 Ref: Nuclear translocation of the cytoplasmic domain of HB-EGF induces gastric cancer invasion. PMID: 22646534 Ref: Liver-intestine cadherin induction by epidermal growth factor receptor is associated with intestinal differentiation of gastric cancer. PMID: 22676223 Ref: Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization. PMID: 22691185 Ref: Tob1 induces apoptosis and inhibits proliferation, migration and invasion of gastric cancer cells by activating Smad4 and inhibiting betacatenin signaling. PMID: 22710759 Ref: Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. PMID: 22751462 Ref: Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PMID: 22802949 Ref: Targeting STAT3 in gastric cancer. PMID: 22834702 Ref: Molecular diagnosis on tissues and cells: how it affects training and will affect practice in the future. PMID: 22846108 Ref: Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models. PMID: 22935382 Ref: Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. PMID: 22977193 Ref: Targetting esophageal and gastric cancers with monoclonal antibodies. PMID: 22978338 Ref: Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy. PMID: 22980219 Ref: Crosstalk between EGFR and integrin affects invasion and proliferation of gastric cancer cell line, SGC7901. PMID: 23109808 Ref: The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer. PMID: 23153332 Ref: [Molecular targeting agents for advanced or recurrent gastric cancer patients]. PMID: 23198568 Ref: Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer. PMID: 23298488 Ref: Trastuzumab (Herceptin) Therapy and ERBB2 (HER2) Genotype PMID: 28520362 |
Ref: Irinotecan resistance is accompanied by upregulation of EGFR and Src signaling in human cancer models. PMID: 22973964 Ref: The role of PGE2-associated inflammatory responses in gastric cancer development. PMID: 23053397 Ref: Antitumor activity of saracatinib (AZD0530), a c-Src/Abl kinase inhibitor, alone or in combination with chemotherapeutic agents in gastric cancer. PMID: 23144237 Ref: Lapatinib acts on gastric cancer through both antiproliferative function and augmentation of trastuzumab-mediated antibody-dependent cellular cytotoxicity. PMID: 23187882 Ref: HER3 overexpression and survival in solid tumors: a meta-analysis. PMID: 23221996 Ref: The role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncology. PMID: 23225792 Ref: A novel proteomics-based clinical diagnostics technology identifies heterogeneity in activated signaling pathways in gastric cancers. PMID: 23372746 Ref: Expression of C-X-C chemokine receptor types 1/2 in patients with gastric carcinoma: Clinicopathological correlations and significance. PMID: 23420470 Ref: Monoclonal antibodies in gastrointestinal cancers. PMID: 23441760 Ref: Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells. PMID: 23445612 Ref: Heterogeneous target protein expression in synchronous multiple gastric carcinomas. PMID: 23469621 Ref: Dominant negative epidermal growth factor receptor inhibits growth of human gastric cancer cells by inducing cell cycle arrest and apoptosis. PMID: 23506429 Ref: [Clinical study of the predictors to neoadjuvant chemotherapy in patients with advanced gastric cancer]. PMID: 23536352 Ref: Potential advantages of CUDC-101, a multitargeted HDAC, EGFR, and HER2 inhibitor, in treating drug resistance and preventing cancer cell migration and invasion. PMID: 23536719 Ref: Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects. PMID: 23555641 Ref: Downregulation of the GnT-V gene inhibits metastasis and invasion of BGC823 gastric cancer cells. PMID: 23563846 Ref: EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. PMID: 23566958 Ref: [Perspectives of the stomach cancer treatment: the introduction of molecular targeted therapy and the hope for cure]. PMID: 23575230 Ref: Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET. PMID: 23578997 Ref: Relationship between expression of EGFR in gastric cancer tissue and clinicopathological features. PMID: 23608326 Ref: PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells. PMID: 23613900 Ref: Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells. PMID: 23681474 Ref: Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model. PMID: 23783223 Ref: Epidermal growth factor receptor gene polymorphisms and gastric cancer in Iran. PMID: 23803102 Ref: Identification of a candidate single-nucleotide polymorphism related to chemotherapeutic response through a combination of knowledge-based algorithm and hypothesis-free genomic data. PMID: 23816762 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part I: Targeting receptor tyrosine kinase gene amplification. PMID: 23819947 Ref: STAT3 is associated with lymph node metastasis in gastric cancer. PMID: 23824569 Ref: CD44(+) gastric cancer cells with stemness properties are chemoradioresistant and highly invasive. PMID: 23833643 Ref: Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells. PMID: 23833649 Ref: Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells. PMID: 23840737 Ref: Carboxyl group footprinting mass spectrometry and molecular dynamics identify key interactions in the HER2-HER3 receptor tyrosine kinase interface. PMID: 23843458 Ref: Analysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions. PMID: 23844533 Ref: Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis. PMID: 23871709 Ref: Genetic variants in epidermal growth factor receptor pathway genes and risk of esophageal squamous cell carcinoma and gastric cancer in a Chinese population. PMID: 23874846 Ref: [Clinical significance of human epidermal growth factor receptor family molecules expression in gastric cancer]. PMID: 23888453 Ref: Towards the goal of personalized medicine in gastric cancer--time to move beyond HER2 inhibition. Part II: Targeting gene mutations and gene amplifications and the angiogenesis pathway. PMID: 23911227 Ref: Cancer stem cells biomarkers in gastric carcinogenesis. PMID: 23949555 Ref: Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis. PMID: 23954221 Ref: Cetuximab enhances TRAIL-induced gastric cancer cell apoptosis by promoting DISC formation in lipid rafts. PMID: 23973713 Ref: H. pylori CagL-Y58/E59 prime higher integrin alpha5beta1 in adverse pH condition to enhance hypochlorhydria vicious cycle for gastric carcinogenesis. PMID: 24009701 Ref: Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer. PMID: 24122977 Ref: A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy. PMID: 24141978 Ref: HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab. PMID: 24146218 Ref: Novel compound PS-101 exhibits selective inhibition in non-small-cell lung cancer cell by blocking the EGFR-driven antiapoptotic pathway. PMID: 24161785 Ref: Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line. PMID: 24263233 Ref: Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells. PMID: 24273605 Ref: Signal transduction of Helicobacter pylori during interaction with host cell protein receptors of epithelial and immune cells. PMID: 24280762 Ref: Cbl-b enhances sensitivity to 5-fluorouracil via EGFR- and mitochondria-mediated pathways in gastric cancer cells. PMID: 24351824 Ref: Relationship between EGF, TGFA, and EGFR Gene Polymorphisms and Traditional Chinese Medicine ZHENG in Gastric Cancer. PMID: 24454509 Ref: Type II cGMP-dependent protein kinase inhibits activation of key members of the RTK family in gastric cancer cells. PMID: 24648957 Ref: Effects of EGFR Inhibitor on Helicobacter pylori Induced Gastric Epithelial Pathology in Vivo. PMID: 25437333 Ref: HER2 driven non-small cell lung cancer (NSCLC): potential therapeutic approaches. PMID: 25806223 |
Ref: Prognostic value of epidermal growth factor receptors in gastric cancer: a survival analysis by Weibull model incorporating long-term survivors. PMID: 23455716 Ref: Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. PMID: 23852704 Ref: Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection. PMID: 23955257 Ref: Clinicopathological significance of MMP-7, laminin gamma2 and EGFR expression at the invasive front of gastric carcinoma. PMID: 24048760 Ref: Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition. PMID: 24070739 Ref: Biomarkers of drugs targeting HER-family signalling in cancer. PMID: 24105684 Ref: TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer. PMID: 24178904 Ref: Association of HER1 amplification with poor prognosis in well differentiated gastric carcinomas. PMID: 24218028 Ref: New whole-body multimodality imaging of gastric cancer peritoneal metastasis combining fluorescence imaging with ICG-labeled antibody and MRI in mice. PMID: 24288123 Ref: Effect of epidermal growth factor receptor status on the outcomes of patients with metastatic gastric cancer: A pilot study. PMID: 24348859 Ref: The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer. PMID: 24410474 Ref: The experimental study on the treatment of cytokine-induced killer cells combined with EGFR monoclonal antibody against gastric cancer. PMID: 24443838 Ref: EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model? PMID: 24454858 Ref: Cetuximab inhibits gastric cancer growth in vivo, independent of KRAS status. PMID: 24467518 Ref: Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization. PMID: 24491355 Ref: SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review. PMID: 24503755 Ref: Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. PMID: 24530706 Ref: Type II cGMP-dependent protein kinase inhibits ligandinduced activation of EGFR in gastric cancer cells. PMID: 24534906 Ref: miR-7 inhibits the invasion and metastasis of gastric cancer cells by suppressing epidermal growth factor receptor expression. PMID: 24573489 Ref: A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors. PMID: 24612546 Ref: Recent advances and future trends in the targeted therapy of metastatic gastric cancer. PMID: 24665840 Ref: Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signaling. PMID: 24668364 Ref: Cortactin expression confers a more malignant phenotype to gastric cancer SGC-7901 cells. PMID: 24696610 Ref: Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4. PMID: 24728052 Ref: Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. PMID: 24743909 Ref: Lapatinib. PMID: 24756789 Ref: The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey. PMID: 24806575 Ref: AKT/ERK activation is associated with gastric cancer cell resistance to paclitaxel. PMID: 24817940 Ref: Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells. PMID: 24840271 Ref: Heat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy. PMID: 24903273 Ref: Mutational and expressional analysis of ERBB3 gene in common solid cancers. PMID: 24909266 Ref: Detection of circulating tumor cells in colorectal and gastric cancer using a multiplex PCR assay. PMID: 24922677 Ref: Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells. PMID: 24945379 Ref: Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo. PMID: 24947902 Ref: The role of targeted therapy for gastrointestinal tumors. PMID: 24957206 Ref: MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer. PMID: 24981249 Ref: Comparison of K-ras mutations in lung, colorectal and gastric cancer. PMID: 25013470 Ref: [Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers]. PMID: 25030589 Ref: The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression. PMID: 25051417 Ref: Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13. PMID: 25085584 Ref: Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors. PMID: 25107918 Ref: HDAC6 sustains growth stimulation by prolonging the activation of EGF receptor through the inhibition of rabaptin-5-mediated early endosome fusion in gastric cancer. PMID: 25111897 Ref: Mycoplasma hyorhinis infection promotes NF-kappaB-dependent migration of gastric cancer cells. PMID: 25136068 Ref: How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. PMID: 25142842 Ref: The role of HER3 in gastric cancer. PMID: 25194439 Ref: High-throughput sequencing and copy number variation detection using formalin fixed embedded tissue in metastatic gastric cancer. PMID: 25372287 Ref: Knockdown of EGFR inhibits growth and invasion of gastric cancer cells. PMID: 25394504 Ref: An increase in integrin-linked kinase non-canonically confers NF-kappaB-mediated growth advantages to gastric cancer cells by activating ERK1/2. PMID: 25398317 Ref: Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer. PMID: 25455899 Ref: Detection of kinase amplifications in gastric adenocarcinomas. PMID: 25558650 Ref: Role of Raf kinase inhibitor protein in Helicobacter pylori-mediated signaling in gastric cancer. PMID: 25597356 Ref: Gastric Cancer: New Drugs - New Strategies. PMID: 26674336 |
Ref: Pb2+ induces gastrin gene expression by extracellular signal-regulated kinases 1/2 and transcription factor activator protein 1 in human gastric carcinoma cells. PMID: 23765435 Ref: Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis. PMID: 24562421 Ref: Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. PMID: 24626858 Ref: Comparison of site-specific gene expression levels in primary tumors and synchronous lymph node metastases in advanced gastric cancer. PMID: 24651981 Ref: Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer. PMID: 25154973 Ref: HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy. PMID: 25157953 Ref: Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer. PMID: 25173363 Ref: Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer. PMID: 25185971 Ref: Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer. PMID: 25306393 Ref: Selective bispecific T cell recruiting antibody and antitumor activity of adoptive T cell transfer. PMID: 25424197 Ref: The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. PMID: 25445175 Ref: Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. PMID: 25473895 Ref: Oxymatrine targets EGFR(p-Tyr845) and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells. PMID: 25527205 Ref: Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. PMID: 25553823 Ref: Assessment and prognostic analysis of EGFR, HER2, and HER3 protein expression in surgically resected gastric adenocarcinomas. PMID: 25565860 Ref: Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in FGFR2 amplified gastric cancer. PMID: 25576915 Ref: Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer. PMID: 25590805 Ref: Cetuximab-induced insulin-like growth factor receptor I activation mediates cetuximab resistance in gastric cancer cells. PMID: 25625229 Ref: Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. PMID: 25649416 Ref: Asporin participates in gastric cancer cell growth and migration by influencing EGF receptor signaling. PMID: 25673058 Ref: Targeted therapy in gastric cancer. PMID: 25706252 Ref: Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. PMID: 25743022 Ref: The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR. PMID: 25820598 Ref: Biologics in combination with chemotherapy for gastric cancer: is this the answer? PMID: 25850442 Ref: EGFR gene polymorphisms -216G>T and -191C>A are risk markers for gastric cancer in Mexican population. PMID: 25867325 Ref: Role of c-mesenchymal-epithelial transition pathway in gastric cancer. PMID: 25881479 Ref: Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer. PMID: 25959250 Ref: Analyses of EGF A61G Gene Variation and Serum EGF Level on Gastric Cancer Susceptibility and Clinicopathological Parameters. PMID: 25964549 Ref: Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer. PMID: 25970779 Ref: A tumor-penetrating recombinant protein anti-EGFR-iRGD enhance efficacy of paclitaxel in 3D multicellular spheroids and gastric cancer in vivo. PMID: 25998561 Ref: alpha-Fetoprotein-Producing Hepatoid Gastric Adenocarcinoma With Osteoclast-Like Giant Cells and Neuroendocrine Differentiation: A Case Study With Molecular Profiling. PMID: 26009570 Ref: Emerging kinase inhibitors of the treatment of gastric cancer. PMID: 26021342 Ref: Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer. PMID: 26034362 Ref: Molecular biomarkers in gastric cancer. PMID: 26052595 Ref: ADRM1-amplified metastasis gene in gastric cancer. PMID: 26052681 Ref: A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? PMID: 26061272 Ref: Impairment of growth of gastric carcinoma by miR-133-mediated Her-2 inhibition. PMID: 26076812 Ref: EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition. PMID: 26081723 Ref: Inhibition of ligand-independent constitutive activation of the Met oncogenic receptor by the engineered chemically-modified antibody DN30. PMID: 26119717 Ref: Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines. PMID: 26137146 Ref: Cortactin promotes colon cancer progression by regulating ERK pathway. PMID: 26151562 Ref: Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase. PMID: 26171055 Ref: The significance of NTR1 expression and its correlation with beta-catenin and EGFR in gastric cancer. PMID: 26215716 Ref: Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity. PMID: 26217940 Ref: PEA3 transcription factors are downstream effectors of Met signaling involved in migration and invasiveness of Met-addicted tumor cells. PMID: 26238631 Ref: Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. PMID: 26260219 Ref: Impact of Cell-surface Antigen Expression on Target Engagement and Function of an Epidermal Growth Factor Receptor x c-MET Bispecific Antibody. PMID: 26260789 Ref: Molecular classification of gastric cancer: Towards a pathway-driven targeted therapy. PMID: 26267324 Ref: Sustained Inhibition of HER3 and EGFR Is Necessary to Induce Regression of HER2-Amplified Gastrointestinal Carcinomas. PMID: 26296355 Ref: KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity. PMID: 26318594 Ref: Erratum to: The significance of NTR1 expression and its correlation with beta-catenin and EGFR in gastric cancer. PMID: 26382737 Ref: Delineation of gastric cancer subtypes by co-regulated expression of receptor tyrosine kinases and chemosensitivity genes. PMID: 26396673 Ref: Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer. PMID: 26401016 Ref: MTHFR C677T Polymorphism is Associated with Tumor Response to Preoperative Chemoradiotherapy: A Result Based on Previous Reports. PMID: 26456456 Ref: Construction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic method. PMID: 26475168 Ref: Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. PMID: 26538117 Ref: Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis. PMID: 26608463 Ref: Hypoxia/lncRNA-AK123072/EGFR pathway induced metastasis and invasion in gastric cancer. PMID: 26884908 Ref: Advances in Imaging: Brain Tumors to Alzheimer's Disease. PMID: 29142857 |
Ref: Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method. PMID: 25487305 Ref: Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients. PMID: 25682441 Ref: Gastrokine 1 inhibits gastrin-induced cell proliferation. PMID: 25752269 Ref: Detection and cultivation of circulating tumor cells in gastric cancer. PMID: 25862542 Ref: Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer. PMID: 26489445 Ref: Rab11-FIP2 promotes the metastasis of gastric cancer cells. PMID: 26502090 Ref: Sulforaphene promotes Bax/Bcl2, MAPK-dependent human gastric cancer AGS cells apoptosis and inhibits migration via EGFR, p-ERK1/2 down-regulation. PMID: 26612919 Ref: Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells. PMID: 26676300 Ref: HER2 overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the QUASAR, FOCUS and PICCOLO colorectal cancer trials. PMID: 26690310 Ref: Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials. PMID: 26697987 Ref: Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors. PMID: 26795388 Ref: Helicobacter pylori Activates Matrix Metalloproteinase 10 in Gastric Epithelial Cells via EGFR and ERK-mediated Pathways. PMID: 26802142 Ref: CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells. PMID: 26830684 Ref: Effect of EGFR and p-AKT Overexpression on Chromosomal Instability in Gastric Cancer. PMID: 26847684 Ref: Erratum to: Linc00152 promotes proliferation in gastric cancer through the EGFR-dependent pathway. PMID: 26860954 Ref: Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients. PMID: 26870185 Ref: OncoBinder facilitates interpretation of proteomic interaction data by capturing coactivation pairs in cancer. PMID: 26872056 Ref: Targeted therapies in gastric cancer treatment: where we are and where we are going. PMID: 26873643 Ref: Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. PMID: 26874901 Ref: Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application. PMID: 26880889 Ref: CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation. PMID: 26983663 Ref: Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer. PMID: 27008850 Ref: Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy. PMID: 27014419 Ref: Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. PMID: 27017273 Ref: Coupling GdDTPA with a bispecific, recombinant protein antiEGFRiRGD complex improves tumor targeting in MRI. PMID: 27035336 Ref: REG4 promotes peritoneal metastasis of gastric cancer through GPR37. PMID: 27036049 Ref: Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells. PMID: 27048593 Ref: Treatment outcome of nimotuzumab plus chemotherapy in advanced cancer patients: a single institute experience. PMID: 27050148 Ref: HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study. PMID: 27069134 Ref: GL-1196 Suppresses the Proliferation and Invasion of Gastric Cancer Cells via Targeting PAK4 and Inhibiting PAK4-Mediated Signaling Pathways. PMID: 27077843 Ref: Synergistic combination of DT-13 and topotecan inhibits human gastric cancer via myosin IIA-induced endocytosis of EGF receptor in vitro and in vivo. PMID: 27105508 Ref: PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells. PMID: 27147579 Ref: Recent insights in the therapeutic management of patients with gastric cancer. PMID: 27156069 Ref: The role of targeted agents in the treatment of advanced gastric cancer: a meta-analysis of randomized controlled trials. PMID: 27212163 Ref: Personalised Treatment in Gastric Cancer: Myth or Reality? PMID: 27215435 Ref: Therapeutic Antibodies in Cancer Therapy. PMID: 27236554 Ref: Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers. PMID: 27275783 Ref: Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo. PMID: 27277844 Ref: The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer. PMID: 27314292 Ref: Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. PMID: 27331626 Ref: Type II cGMPdependent protein kinase inhibits EGFinduced JAK/STAT signaling in gastric cancer cells. PMID: 27357186 Ref: Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. PMID: 27384994 Ref: Molecular-targeted first-line therapy for advanced gastric cancer. PMID: 27432490 Ref: Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3beta/Foxp3 Axis. PMID: 27432879 Ref: Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation. PMID: 27437872 Ref: Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. PMID: 27468100 Ref: EGFR regulates macrophage activation and function in bacterial infection. PMID: 27482886 Ref: Cross-linked hyaluronic acid gel inhibits metastasis and growth of gastric and hepatic cancer cells: in vitro and in vivo studies. PMID: 27589842 Ref: Management of advanced gastric cancer: An overview of major findings from meta-analysis. PMID: 27655725 Ref: Anti-proliferation effects of trifolirhizin on MKN45 cells and possible mechanism. PMID: 27666116 Ref: Cbl-b regulates the sensitivity of cetuximab through ubiquitin-proteasome system in human gastric cancer cells. PMID: 27685907 Ref: Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer. PMID: 27738318 Ref: The prospect of patritumab for treating non-small cell lung cancer. PMID: 27744717 Ref: Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm. PMID: 27765925 Ref: Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention. PMID: 27766079 Ref: The Significant Role of Cyclin D1 in the Synergistic Growth-inhibitory Effect of Combined Therapy of Vandetanib with 5-Fluorouracil for Gastric Cancer. PMID: 27798882 Ref: Targeted therapy of multiple liver metastases after resected solitary gastric metastasis and primary pulmonary adenocarcinoma. PMID: 27829227 Ref: Therapeutics Targeting FGF Signaling Network in Human Diseases. PMID: 27992319 Ref: MiR-520b/e Regulates Proliferation and Migration by Simultaneously Targeting EGFR in Gastric Cancer. PMID: 27997901 Ref: Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. PMID: 28078044 Ref: Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K. PMID: 28244453 |
Ref: Impact of c-erbB-2 protein on 5-year survival rate of gastric cancer patients after surgery: a cohort study and meta-analysis. PMID: 26549693 Ref: Prostaglandin E2 stimulates urokinase-type plasminogen activator receptor via EP2 receptor-dependent signaling pathways in human AGS gastric cancer cells. PMID: 27377703 Ref: Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort. PMID: 27524418 Ref: Transducin (beta)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway. PMID: 27694893 Ref: Distinct expression profile of key molecules in crawling-type early gastric carcinoma. PMID: 27734272 Ref: Fucosyltransferase-4 and Oligosaccharide Lewis Y Antigen as potentially Correlative Biomarkers of Helicobacter pylori CagA Associated Gastric Cancer. PMID: 27757838 Ref: Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization. PMID: 27864121 Ref: CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer. PMID: 27867015 Ref: Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-alpha signalling pathways. PMID: 27878499 Ref: Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. PMID: 27933395 Ref: Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. PMID: 28102288 Ref: Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips. PMID: 28111342 Ref: RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src. PMID: 28123301 Ref: [A Case of Synchronous Double Cancer of the Lung and Stomach That Responded to Cisplatin and S-1 Combination Chemotherapy]. PMID: 28174383 Ref: Apatinib as post second-line therapy in EGFR wild-type and ALK-negative advanced lung adenocarcinoma. PMID: 28176910 Ref: Heat-shock protein 27 (HSP27, HSPB1) is synthetic lethal to cells with oncogenic activation of MET, EGFR and BRAF. PMID: 28182330 Ref: Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis. PMID: 28199988 Ref: Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas. PMID: 28223233 Ref: Asparaginyl endopeptidase improves the resistance of microtubule-targeting drugs in gastric cancer through IQGAP1 modulating the EGFR/JNK/ERK signaling pathway. PMID: 28223821 Ref: Nuclear Drosha enhances cell invasion via an EGFR-ERK1/2-MMP7 signaling pathway induced by dysregulated miRNA-622/197 and their targets LAMC2 and CD82 in gastric cancer. PMID: 28252644 Ref: Dysregulation of mRNA profile in cisplatin-resistant gastric cancer cell line SGC7901. PMID: 28275299 Ref: E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells. PMID: 28334634 Ref: Amorphous Silica Particles Relevant in Food Industry Influence Cellular Growth and Associated Signaling Pathways in Human Gastric Carcinoma Cells. PMID: 28336852 Ref: Study on the proliferation of human gastric cancer cell AGS by activation of EGFR in H2O2. PMID: 28338196 Ref: Reduction of miR1323p contributes to gastric cancer proliferation by targeting MUC13. PMID: 28339011 Ref: HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy. PMID: 28363756 Ref: MicroR-545 mediates colorectal cancer cells proliferation through up-regulating epidermal growth factor receptor expression in HOTAIR long non-coding RNA dependent. PMID: 28364379 Ref: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis. PMID: 28393839 Ref: Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer. PMID: 28399526 Ref: Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer. PMID: 28418920 Ref: Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells. PMID: 28454117 Ref: Efficacy and safety of different molecular targeted agents based on chemotherapy for gastric cancer patients treatment: a network meta-analysis. PMID: 28477027 Ref: Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer cells. PMID: 28479384 Ref: w09, a novel autophagy enhancer, induces autophagy-dependent cell apoptosis via activation of the EGFR-mediated RAS-RAF1-MAP2K-MAPK1/3 pathway. PMID: 28513279 Ref: miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer. PMID: 28534999 Ref: miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer. PMID: 28535014 Ref: Nivolumab Therapy for Synchronous ALK-Positive Lung Cancer and Gastric Cancer. PMID: 28559820 Ref: Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer. PMID: 28640116 Ref: Sym015: A Highly Efficacious Antibody Mixture against MET-Amplified Tumors. PMID: 28679766 Ref: Role of ARPC2 in Human Gastric Cancer. PMID: 28694563 Ref: Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment. PMID: 28736628 Ref: Biologic therapy in esophageal and gastric malignancies: current therapies and future directions. PMID: 28736629 Ref: Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing. PMID: 28744403 Ref: CXCL12/SDF-1alpha induces migration via SRC-mediated CXCR4-EGFR cross-talk in gastric cancer cells. PMID: 28781651 Ref: EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patientderived xenografts with cetuximab. PMID: 28849161 Ref: siRNA-mediated inactivation of HER3 improves the antitumour activity and sensitivity of gefitinib in gastric cancer cells. PMID: 28881753 Ref: Inhibition of Hes1 enhances lapatinib sensitivity in gastric cancer sphere-forming cells. PMID: 28959362 Ref: HCRP1 downregulation confers poor prognosis and induces chemoresistance through regulation of EGFR-AKT pathway in human gastric cancer. PMID: 28963677 Ref: EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release. PMID: 28969039 Ref: Efficiency of low dosage apatinib in post-first-line treatment of advanced lung adenocarcinoma. PMID: 29029508 Ref: In vivo evaluation of cetuximab-conjugated poly(gamma-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts. PMID: 29033568 Ref: Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature. PMID: 29034239 Ref: The H19-PEG10/IGF2BP3 axis promotes gastric cancer progression in patients with high lymph node ratios. PMID: 29088808 Ref: Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. PMID: 29094049 Ref: In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. PMID: 29125233 Ref: Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis. PMID: 29237412 Ref: [Checkpoint Inhibitors in the Treatment of Upper Gastrointestinal Tract Tumors]. PMID: 29239193 Ref: Gene mutations in stool from gastric and colorectal neoplasia patients by next-generation sequencing. PMID: 29307989 Ref: First-line dose-dense chemotherapy with docetaxel, cisplatin, folinic acid and 5-fluorouracil (DCF) plus panitumumab in patients with locally advanced or metastatic cancer of the stomach or gastroesophageal junction: final results and biomarker analysis f PMID: 29340092 Ref: Los receptores epidermicos humanos en el cancer gastrico: alteraciones moleculares y su papel como diana terapeutica. PMID: 29414960 Ref: Chromosomal breaks at FRA18C: association with reduced DOK6 expression, altered oncogenic signaling and increased gastric cancer survival. PMID: 29872697 |
Ref: Frequent Coamplification of Receptor Tyrosine Kinase and Downstream Signaling Genes in Japanese Primary Gastric Cancer and Conversion in Matched Lymph Node Metastasis. PMID: 27779515 Ref: The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration. PMID: 28183250 Ref: Epidermal growth factor receptor inhibition downregulates Helicobacter pylori-induced epithelial inflammatory responses, DNA damage and gastric carcinogenesis. PMID: 28473630 Ref: Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors. PMID: 28859471 Ref: Gastric cancer: immunohistochemical classification of molecular subtypes and their association with clinicopathological characteristics. PMID: 29046940 Ref: Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment. PMID: 29138285 Ref: PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines. PMID: 29150923 Ref: Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer. PMID: 29256147 Ref: Chk1 activation attenuates sensitivity of lapatinib in HER2-positive gastric cancer. PMID: 29271513 Ref: EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas. PMID: 29278885 Ref: Global gene expression analysis of knockdown Triosephosphate isomerase (TPI) gene in human gastric cancer cell line MGC-803. PMID: 29307852 Ref: Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway. PMID: 29328433 Ref: Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer. PMID: 29344282 Ref: Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients. PMID: 29409051 Ref: Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors. PMID: 29416720 Ref: Bispecific tumor-penetrating protein anti-EGFR-iRGD efficiently enhances the infiltration of lymphocytes in gastric cancer. PMID: 29416923 Ref: Characterization and validation of potential therapeutic targets based on the molecular signature of patient-derived xenografts in gastric cancer. PMID: 29433585 Ref: The constitutively active PKG II mutant effectively inhibits gastric cancer development via a blockade of EGF/EGFR-associated signalling cascades. PMID: 29434677 Ref: Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways. PMID: 29434871 Ref: EGFR-targeted photodynamic therapy by curcumin-encapsulated chitosan/TPP nanoparticles. PMID: 29445279 Ref: Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance. PMID: 29450946 Ref: The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells. PMID: 29455656 Ref: Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer. PMID: 29467883 Ref: Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk. PMID: 29468433 Ref: A cross-talk between integrin beta4 and epidermal growth factor receptor induces gefitinib chemoresistance to gastric cancer. PMID: 29618949 Ref: The role of propranolol as a radiosensitizer in gastric cancer treatment. PMID: 29636598 Ref: Dual silencing of EGFR and HER2 enhances the sensitivity of gastric cancer cells to gefitinib. PMID: 29637613 Ref: Methylation-induced silencing of SPG20 facilitates gastric cancer cell proliferation by activating the EGFR/MAPK pathway. PMID: 29673586 Ref: Effects of miR1385p and miR2045p on the migration and proliferation of gastric cancer cells by targeting EGFR. PMID: 29693184 Ref: Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer. PMID: 29719612 Ref: Association between the SNPs of the TOB1 gene and gastric cancer risk in the Chinese Han population of northeast China. PMID: 29721046 Ref: Long non-coding RNA UCA1 upregulation promotes the migration of hypoxia-resistant gastric cancer cells through the miR-7-5p/EGFR axis. PMID: 29723509 Ref: EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes. PMID: 29740957 Ref: Synthesis and antitumor activity of novel 6,7,8-trimethoxy N-aryl-substituted-4-aminoquinazoline derivatives. PMID: 29903662 Ref: PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRbeta in gastric cancer cells. PMID: 29935031 Ref: Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples. PMID: 29951752 Ref: Tumorpenetrating peptide fused EGFR singledomain antibody enhances radiation responses following EGFR inhibition in gastric cancer. PMID: 29956805 Ref: Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells. PMID: 30021363 Ref: Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma. PMID: 30038504 Ref: Lapatinib. PMID: 30069757 Ref: CT textural analysis of gastric cancer: correlations with immunohistochemical biomarkers. PMID: 30087428 Ref: Caveolin-1 contributes to anoikis resistance in human gastric cancer SGC-7901 cells via regulating Src-dependent EGFR-ITGB1 signaling. PMID: 30088837 Ref: Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071). PMID: 30105460 Ref: Long Noncoding RNA EGFR-AS1 Promotes Cell Proliferation by Increasing EGFR mRNA Stability in Gastric Cancer. PMID: 30138934 Ref: Clinical use of trastuzumab combined with different chemotherapy regimens in multi-line treatment of advanced human epidermal growth factor receptor 2-positive gastric cancer: A case report. PMID: 30214596 Ref: What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies? PMID: 30231398 Ref: NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR. PMID: 30237423 Ref: Expression of Lrig1, a negative regulator of EGFR, is dynamically altered during different stages of gastric carcinogenesis. PMID: 30248341 Ref: Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis. PMID: 30250552 Ref: Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein. PMID: 30254439 Ref: Clinicopathological significance of RCAN2 production in gastric carcinoma. PMID: 30307052 Ref: Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1. PMID: 30320337 Ref: The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities. PMID: 30323967 Ref: The safety of apatinib for the treatment of gastric cancer. PMID: 30324820 Ref: Changes in HER2 Expression and Amplification Status Following Preoperative Chemotherapy for Gastric Cancer. PMID: 30348707 |